Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Biomed Environ Sci. 2014 May;27(5):388-90. doi: 10.3967/bes2014.065.

Antimicrobial susceptibility of Streptococcus sp. to quinupristin-dalfopristin in China.

Author information

  • 1State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou 310003, Zhejiang, China.
  • 2Laboratory of Microbiology, Chaoyang District Center for Disease Control and Prevention, Beijing 100021, China.

Abstract

This study aimed to determine the in vitro activity of quinupristin-alfopristin against Streptococcus sp. isolated in China. This agent is not yet available for clinical use, but it has been tested against a high proportion of resistant Staphylococcus aureus strains. A total of 156 streptococcal isolates, which were recovered from various geographic areas and diseases, were tested using the Etest (AB Biodisk, Solna, Sweden). Quinupristin-alfopristin showed excellent activity against all of the tested streptococci isolates. These results provide useful data for the clinical use of quinupristin-alfopristin in China.

Copyright © 2014 The Editorial Board of Biomedical and Environmental Sciences. Published by China CDC. All rights reserved.

PMID:
24827721
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Chinese Center for Disease Control and Prevention
    Loading ...
    Write to the Help Desk